CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | Cline Darren S Director | Grant or award · Common Stock (Right to Buy) | +26,764 | 26,764 | ||
| 2024-06-13 | CROWELL GAYLE A Director | Grant or award · Common Stock (Right to Buy) | +26,764 | 26,764 | ||
| 2024-06-13 | Bruhn Suzanne Louise Director | Grant or award · Common Stock (Right to Buy) | +26,764 | 26,764 | ||
| 2024-06-13 | Curnutte John T Director | Grant or award · Common Stock (Right to Buy) | +26,764 | 26,764 | ||
| 2024-06-13 | Krognes Steve E. Director | Grant or award · Common Stock (Right to Buy) | +53,528 | 53,528 | ||
| 2024-05-02 | Cummings Keith Lamont Chief Financial Officer | Option exercise | +21,000 | $2.08 | $44K | 271,713 |
| 2024-05-02 | Cummings Keith Lamont Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −21,000 | 76,047 | ||
| 2024-01-23 | Lefebvre Eric Chief Medical Officer | Grant or award | +42,900 | 199,820 | ||
| 2024-01-23 | Lefebvre Eric Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,800 | 85,800 | ||
| 2024-01-23 | Hull Hans Chief Business Officer | Grant or award | +31,500 | 216,569 | ||
| 2024-01-23 | Hull Hans Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +63,000 | 63,000 | ||
| 2024-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award | +31,500 | 86,746 | ||
| 2024-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award · Stock Option (Right to Buy) | +63,000 | 63,000 | ||
| 2024-01-23 | Cummings Keith Lamont Chief Financial Officer | Grant or award | +55,250 | 249,855 | ||
| 2024-01-23 | Cummings Keith Lamont Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +110,500 | 110,500 | ||
| 2024-01-23 | Cheung Lily Chief Human Resource Officer | Grant or award | +26,000 | 26,795 | ||
| 2024-01-23 | Cheung Lily Chief Human Resource Officer | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2024-01-23 | Coulie Bernard President and CEO | Grant or award | +128,150 | 444,532 | ||
| 2024-01-23 | Coulie Bernard President and CEO | Grant or award · Stock Option (Right to Buy) | +256,300 | 256,300 | ||
| 2024-01-17 | Cummings Keith Lamont Chief Financial Officer | Sale 10b5-1 | −9,781 | $17.23 | $169K | 194,605 |
Page 6 of 8 · 160 trades